A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients. The result is in striking contrast to a previous trial in which oral…
in Health
Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients
